Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes RANCHO CUCAMONGA, CA / ACCESS Newswire / March 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) to ...
Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes RANCHO CUCAMONGA, CA / ACCESS ...
The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.
The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, ...
Dry suction is noninferior to wet suction in terms of diagnostic accuracy in endoscopic ultrasound–guided fine-needle biopsy ...
Thus the 1.0 mL label contributes to Patient Blood Management. The safePICO blood gas syringe is already barcoded, helping you match the sample with the correct patient. With the FLEXLINK data ...
STEQEYMA® (ustekinumab-stba) is Celltrion's biosimilar to STELARA® (ustekinumab), which was launched on March 12, 2025 ...
Mid-Day on MSN1d
Mass Japanese Encephalitis vaccination drive begins in PuneWith the Guillain-Barré Syndrome (GBS) outbreak now over, the Pune Municipal Corporation (PMC) has initiated a large-scale ...
As a result, the actual amount of acetaminophen in the syringe was less than intended; nevertheless, 64 participants were able to measure a dose within 0.5 mL of the correct dosage. Furthermore ...
The FDA approved another set of denosumab biosimilars, Conexxence/Bomyntra (denosumab-bnht), expanding treatment options for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback